RCPath CPD accredited
Co-presenters: Dr Ashley Hammond – Bristol, Professor Alastair Hay – Bristol, Professor Peter Wilson – London
Chaired by: Professor Philip Howard, Leeds
– – – – –
If you require a certificate of attendance, details of how to obtain will appear at the end of the webinar.
Please note that once you have completed your details on the form, the certificate will be generated so please be ready to download your certificate immediately. We would like to inform delegates that each time a certificate is generated, we will be notified with details.
If you have any problems creating or downloading your certificate please contact Esme Carruthers at email@example.com
Philip Howard is Consultant Pharmacist in Antimicrobials at the Leeds Teaching Hospitals NHS Trust and Honorary Visiting Professor at Leeds University. He is the President of the British Society of Antimicrobial Chemotherapy.
He is a member of the UK Dept of Health advisory group on AMR & HCAI and the NICE common infections guidelines group.
His research interests include Antimicrobial Stewardship and antibiotic shortages. He has been involved in AMS education and training across the world. He’s a Fellow of Royal Pharmaceutical Society, and has won the GHP/GSK/UKCPA Clinical Leadership Award, the UKCPA Lifetime Achievement Award and an OBE for his services to healthcare.
I qualified with Distinction in Medicine from Sheffield Medical School in 1991. After flirting hospital adult medicine (MRCP) and paediatrics (DCH) I saw the light and became a General Practitioner in 1997 (MRCGP 1997, FRCGP 2012).
I joined the Centre for Academic Primary Care (CAPC) at the University of Bristol in 2001 and I lead the CAPC infection research group, which conducts multidisciplinary research to improve the management of acute infections and the use of antibiotics in primary care. We collaborate with colleagues nationally and internationally, particularly via the NIHR School of Primary Care Research, and with like-minded researchers at the Universities of Cardiff, Oxford, London, Southampton and Utrecht.
I am passionate supporter of the NHS, in clinical practice (Concord Medical Centre, Bristol) and in conducting research to improve the lives of our patients (and hopefully the quality of our professional lives too).
In have held over £40M in research grants and published over 120 original papers in peer reviewed journals. My research has been recognised by the award of three prestigious national research fellowships (including NIHR Research Professor), three RCGP Research Paper of the Year awards, and the RCGP John Fry Award (2012). In 2019 I became an NIHR Senior Investigator and in 2020 I was awarded Hon FRCPCH.
I obtained a BSc(Hons) in Infectious Diseases from the University of Edinburgh in 2009, and went on to obtain a MSc in Public Health Research at the same institution in 2010. I then moved to Bristol to work for Public Health England South West for a short time, then returned to academia in 2013 where I began my PhD at the University of Bristol, focused on antimicrobial resistant urinary and faecal isolates from children which I obtained in 2016.
When I began my PhD, funded by the NIHR School of Primary Care Research, I was based within the Centre for Academic Primary Care (CAPC) at the University of Bristol, and have remined there ever since. I am currently a Senior Research Associate and a key member of the CAPC infection research group, which conducts multidisciplinary research to improve the management of acute infections and the use of antibiotics in primary care. My main research interests have mostly been around the relationship between antibiotic prescribing in primary care and antimicrobial resistance.
I have a growing reputation for high quality, impactful research contributions within the field of antimicrobial resistance. This includes a highly cited systematic review published in the BMJ (2016) focused on prevalence of antimicrobial resistance in paediatric urinary infections and associations with antibiotic use. I also recently conducted an ecological study exploring associations between primary care antibiotic prescribing and antimicrobial resistance in urinary E. coli in Bristol and was the first study of its kind to explore at a population-level the relationship between primary care antibiotic prescribing and resistance.
I recently secured a prestigious BMA Foundation Kathleen Harper Award to investigate the emergence of nitrofurantoin resistance in urinary E. coli and associations with antibiotic prescribing in England.
I trained at Cambridge and UCLH and I have been consultant microbiologist at UCLH since 1990. I have particular responsibility for antibiotic advice and infection control in critical care. I also help with infection control advice for Camden and Islington. I set up wound surveillance in the Trust which provides surgeons with detailed information on wound infections. I am chairman of the Specialty Training Committee for microbiology for London and the national critical care bacteremia surveillance (ICCQIP).
I have a research interest in the treatment and prevention of transmission of hospital-acquired infection. I have run trials on innovations in the control of infection such as isolation rooms, patient screens, new cleaning methods, diagnostics and antibiotics. I helped design an infection resistant computer keyboard. I have advised trials on diagnosis of sore throat and urinary infection.